Use of Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions

Details for Australian Patent Application No. 2002300876 (hide)

Owner National Institute of Health Claragen Inc.

Inventors Zhang, Zhongjian; Mukherjee, Anil B.; Pilon, Aprile L

Agent Spruson & Ferguson

Pub. Number AU-B-2002300876

Parent 77074

Filing date 5 September 2002

Wipo publication date 20 February 2003

Acceptance publication date 13 July 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002300876

13 July 2006 Application Accepted

  Published as AU-B-2002300876

9 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300877-Filter Housing

2002300875-Preventing Contaminant Build-Up in Beer Lines